Peakdale Molecular Reinforces its Commitment to Science and Extends its Discovery Park Lease
News Mar 02, 2016
Peakdale Molecular has extended its Discovery Park lease for a further ten years. The company, which is part of the Concept Life Sciences group, has been a tenant in Sandwich, Kent for six years and the lease renewal further signifies its commitment to the local area. Peakdale operates laboratory facilities at Discovery Park with the capacity for up to 50 chemists.
Commenting on the extension Paul Barber, Managing Director of Discovery Park said: “Peakdale Molecular has been present at Discovery Park since its launch in 2012, it was one of just five companies at the start and there are now over 125 companies. I am delighted that they have remained committed to Discovery Park and the facilities it offers.”
Peakdale’s Chief Operating Officer, Dr Paul Doyle added: “Discovery Park is one of Europe’s leading science and technology parks and home to a host of international companies. The Park is a vibrant hub of activity and offers the opportunity to share, engage and connect with other science based organisations; something we find incredibly valuable.
“Since the acquisition by Concept Life Sciences we have undergone a period of change which is set to transform into accelerated growth throughout 2016 and onwards. Securing a further 10-year tenancy at Discovery Park is testament to this growth period and indicates our ongoing commitment to our passionate and dedicated workforce.” In addition to the Sandwich site the company’s headquarters are located in the Peak District. Around 70 scientific staff are located here, with the capacity for 100 in total.
Michael Fort, Chairman of Concept Life Sciences, said: “The Discovery Park in Sandwich is a world renowned centre for science and technology and provides the perfect location for Peakdale which has over two decades of experience of supporting the pharmaceutical and biotech industries. Whilst Peakdale has its own positive reputation we have also found that being housed at Discovery Park also greatly assists with recruitment and we have been able to attract some of the brightest and best scientists to our team.”
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE
Researchers Discover Key Link Between Mitochondria and Cocaine AddictionNews
Researchers were able to block response in mitochondria to cocaine.READ MORE